Difference between revisions of "Hsp 27"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 52: | Line 52: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:42, 10 March 2015
| Hsp 27 | |
|---|---|
| Substrate peptide name | Hsp 27 |
| Synonyms | Hsp25 |
| Determination type | In vitro |
| Source | Mus musculus
Homo sapiens |
| Subcellular localization | Associated to plasma membrane and cytoskeletal elements |
| Swissprot ID | P14602 |
| Reactive glutamines | Q31, Q190 |
| Reactive lysines | K209 |
| Substrate sequence | FESRAQLGGPE
SRLFDQAFGLP EQSGAK |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:8093449 |
| Notes | |
